Literature DB >> 6445865

Haptens bound to self IgG induce immunologic tolerance, while when coupled to syngeneic spleen cells they induce immune suppression.

Y Borel.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6445865     DOI: 10.1111/j.1600-065x.1980.tb00308.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  17 in total

1.  Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness.

Authors:  Y Kang; M Melo; E Deng; R Tisch; M El-Amine; D W Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Gene therapy in the treatment of autoimmune diseases.

Authors:  G C Tsokos; G T Nepom
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 3.  New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins.

Authors:  Margaret V Ragni
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

4.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".

Authors:  Anne S De Groot; Leonard Moise; Julie A McMurry; Erik Wambre; Laurence Van Overtvelt; Philippe Moingeon; David W Scott; William Martin
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

Review 5.  Inhibitors - cellular aspects and novel approaches for tolerance.

Authors:  D W Scott
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

6.  B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells.

Authors:  Jonathan Skupsky; Ai-Hong Zhang; Yan Su; David W Scott
Journal:  Mol Ther       Date:  2010-05-18       Impact factor: 11.454

7.  Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis.

Authors:  R K Agarwal; Y Kang; E Zambidis; D W Scott; C C Chan; R R Caspi
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 8.  From nonspecific to specific immunosuppression: facts and speculation.

Authors:  Y Borel
Journal:  Springer Semin Immunopathol       Date:  1984

9.  Enzyme-albumin polymers. New approaches to the use of enzymes in medicine.

Authors:  M J Poznansky
Journal:  Appl Biochem Biotechnol       Date:  1984       Impact factor: 2.926

Review 10.  Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics.

Authors:  Timo Rath; Kristi Baker; Jennifer A Dumont; Robert T Peters; Haiyan Jiang; Shuo-Wang Qiao; Wayne I Lencer; Glenn F Pierce; Richard S Blumberg
Journal:  Crit Rev Biotechnol       Date:  2013-10-24       Impact factor: 8.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.